Sentri7 Analytics on Ipad
HealthFebruary 12, 2020

Case study: Targeting high-cost antibiotics to decrease pharmacy spend and improve overall patient care

This case study explores how a health system customer utilized Sentri7 to target high-cost antibiotics, to decrease spend and uphold high-quality patient care.

Looking across a large health system enterprise, a system director of pharmacy saw an opportunity to educate prescribers about a high-cost antibiotic to improve appropriate prescribing in accordance to the system’s AMS program. The antibiotic, ertapenem (INVANZ), has been considered a niche carbapenem due to its lack of antipseudomonal activity. While its once daily dosing is beneficial in outpatient or home infusion settings, it was identified as a target for an inpatient drug initiative in five key hospitals.

Download the case study


Trusted real-time alerts and evidence-based guidance to ensure at-risk patients receive the right care at the right time, every time.

Sentri7's sophisticated algorithms identify at-risk patients in real-time by breaking down data silos that exist across hospitals and driving consistent clinical action. All to improve patient outcomes and hospital performance.
Back To Top